| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433191A1 Aspartate derivative of amlodipine as calcium channel antagonist |
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/11/2002 | CA2432959A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221438A2 Amlodipine mesylate salts |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220909A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220870A1 Metal-binding compounds and uses therefor |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220830A1 Systems and methods for opening obstructed biological conduits |
| 07/10/2002 | EP1220679A1 Cell-based gene therapy for the pulmonary system |
| 07/10/2002 | EP1073451B1 Deltorphine for treating ischemia |
| 07/10/2002 | EP0973793B1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 07/10/2002 | EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0698203B1 Composition comprising bradykinin for selective opening of abnormal brain tissue capillaries |
| 07/10/2002 | EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358191A N-pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358189A C-2A pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358174A New Compounds |
| 07/10/2002 | CN1358172A Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358092A Pharmaceutical composition containing sibutramine and orlistat |
| 07/10/2002 | CN1358091A Estrogen receptor-beta ligands |
| 07/10/2002 | CN1358063A Effervescent green tea extract formulation |
| 07/10/2002 | CN1358062A 巨噬细胞清除剂受体拮抗剂 Macrophage scavenger receptor antagonists |
| 07/10/2002 | CN1357368A Health beverage |
| 07/10/2002 | CN1357364A Chinese medicine for treating bradyrhythmia caused by hypotension |
| 07/10/2002 | CN1357339A Chinese herbal medicine for treating pile and its recipe and prepn process |
| 07/10/2002 | CN1357268A Beverage capable of depressing blood pressure and clearing away internal heat |
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/10/2002 | CN1087174C Health tea for reducing blood sugar, blood fat |
| 07/09/2002 | US6417394 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| 07/09/2002 | US6417360 Heterocyclic sulfonamides |
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417212 Modulators of peroxisome proliferator activated receptors |
| 07/09/2002 | US6417204 Cardiovascular disoders |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/09/2002 | CA2048212C Sulfonamide derivatives |
| 07/09/2002 | CA2036307C 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| 07/08/2002 | CA2366780A1 Stabilized liquid preparation of the protease which activates blood coagulation factor vii, or of its proenzyme |
| 07/04/2002 | WO2002052267A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |